This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Though hospice deal volume dipped in 2022 compared to previous years, five particular transactions could paint a larger picture of where investors see value in the space. The agreement marked not only one of the largest deals in hospice, but also signaled increasing interest among payers to operate health care provider companies.
As Addus HomeCare Corporation (NASDAQ: ADUS) sinks teeth into acquisitions, the company will be taking smaller bites when it comes to hospice deals. Addus has indicated for roughly the last year that it will orient its M&A strategy towards its homehealth and personal care services, with hospice becoming less of a priority.
Centers for Medicare & Medicaid Services (CMS) allowed Medicare Advantage (MA) plans to offer non-skilled home care services as a supplemental benefit. In 2022, close to 15% of all MA plans – about 1,000 in total – offer in-home support services, according to Washington, D.C.-based As of 2019, the U.S.
Addus HomeCare Corporation’s (NASDAQ: ADUS) is shifting its M&A strategy away from hospice deals to focus on its homehealth and personal care businesses. Texas-based Addus provides personal, homehealth and hospice care across 207 locations in 22 states, reaching roughly 46,500 patients annually.
Disruption in homehealth reimbursement has an influence on the hospice mergers and acquisitions market, particularly among the rising number of companies offering both services. This started to level off late last year and in early 2022. Companies like LHC Group (NASDAQ: LHCG), Amedisys Inc.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content